JP6966197B2 - 赤血球検出 - Google Patents

赤血球検出 Download PDF

Info

Publication number
JP6966197B2
JP6966197B2 JP2016553606A JP2016553606A JP6966197B2 JP 6966197 B2 JP6966197 B2 JP 6966197B2 JP 2016553606 A JP2016553606 A JP 2016553606A JP 2016553606 A JP2016553606 A JP 2016553606A JP 6966197 B2 JP6966197 B2 JP 6966197B2
Authority
JP
Japan
Prior art keywords
binding
red blood
assay
sample
antibodies
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2016553606A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017508961A (ja
JP2017508961A5 (https=
Inventor
ジャニーヌ スコット ロブ
アンドリュー ゴードン ロブ
デイヴィッド クーパー ロブソン
Original Assignee
キュービーディー（キューエス−アイピー）リミテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by キュービーディー（キューエス−アイピー）リミテッド filed Critical キュービーディー（キューエス−アイピー）リミテッド
Publication of JP2017508961A publication Critical patent/JP2017508961A/ja
Publication of JP2017508961A5 publication Critical patent/JP2017508961A5/ja
Application granted granted Critical
Publication of JP6966197B2 publication Critical patent/JP6966197B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/80—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood groups or blood types or red blood cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/554—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being a biological cell or cell fragment, e.g. bacteria, yeast cells
    • G01N33/555—Red blood cell

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Mycology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
JP2016553606A 2014-02-21 2015-02-20 赤血球検出 Active JP6966197B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB1403115.7 2014-02-21
GB201403115A GB201403115D0 (en) 2014-02-21 2014-02-21 Red blood cell detection
PCT/GB2015/050502 WO2015124947A1 (en) 2014-02-21 2015-02-20 Red blood cell detection

Publications (3)

Publication Number Publication Date
JP2017508961A JP2017508961A (ja) 2017-03-30
JP2017508961A5 JP2017508961A5 (https=) 2020-04-09
JP6966197B2 true JP6966197B2 (ja) 2021-11-10

Family

ID=50482614

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016553606A Active JP6966197B2 (ja) 2014-02-21 2015-02-20 赤血球検出

Country Status (7)

Country Link
US (1) US10613102B2 (https=)
EP (1) EP3108247A1 (https=)
JP (1) JP6966197B2 (https=)
AU (1) AU2015220566B2 (https=)
CA (1) CA2939789C (https=)
GB (1) GB201403115D0 (https=)
WO (1) WO2015124947A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017130829A1 (ja) * 2016-01-25 2017-08-03 学校法人北里研究所 マイクロアレイ、マイクロアレイの製造方法、検査方法、及び検査キット
CN113092793A (zh) * 2021-04-16 2021-07-09 江苏力博医药生物技术股份有限公司 一种检测Rh血型抗原的方法、系统及其应用
CN116027022A (zh) * 2023-01-06 2023-04-28 苏州鼎实医疗科技有限公司 免疫清洁剂及其制备方法
CN116466080B (zh) * 2023-03-30 2026-04-07 国药集团动物保健股份有限公司 一种抗原含量的检测方法
CN121182741A (zh) * 2025-11-24 2025-12-23 国家心血管病中心 一种从全血中快速分离红细胞的方法和装置

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4376110A (en) 1980-08-04 1983-03-08 Hybritech, Incorporated Immunometric assays using monoclonal antibodies
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US5225539A (en) 1986-03-27 1993-07-06 Medical Research Council Recombinant altered antibodies and methods of making altered antibodies
US4946778A (en) 1987-09-21 1990-08-07 Genex Corporation Single polypeptide chain binding molecules
US5101017A (en) 1987-04-06 1992-03-31 New York Blood Center, Inc. Antibodies for providing protection against P. vivax malaria infection
US5086002A (en) 1987-09-07 1992-02-04 Agen Biomedical, Ltd. Erythrocyte agglutination assay
IL87768A (en) * 1987-09-17 1994-12-29 Agen Ltd Blood assay including erythrocyte agglutination and reagent for the assay comprising conjugate of erythrocyte binding molecule and analyte binding molecule
WO1990000614A1 (en) 1988-07-13 1990-01-25 Baylor College Of Medicine Receptor specific proteins and their use in receptor typing
ATE428918T1 (de) 2001-01-23 2009-05-15 Univ Dublin City Lumineszenz-detektor
JP3383649B2 (ja) 2001-02-23 2003-03-04 香川県 犯罪鑑識用微量血液型判定組成物、方法およびキット
DE60219642T2 (de) 2001-09-04 2008-01-17 Iq Corp. B.V. Bestimung und quantifizierung von erythrocytenpopulation in proben
US20050009198A1 (en) 2001-09-11 2005-01-13 Maccraith Brian Luminescence-based sensor assembly
DE10330981B4 (de) 2003-07-09 2010-04-01 Medion Diagnostics Ag Vorrichtung und Verfahren zur simultanen Durchführung von Blutgruppenbestimmung, Serumgegenprobe und Antikörpersuch-Test
TWI337868B (en) 2004-05-21 2011-03-01 Tzu Chi Buddhist General Hospital Method for extracting extract from chaenomeles lagenaria and the applications thereof
GB0506183D0 (en) 2005-03-24 2005-05-04 Univ Edinburgh Antigen detection
GB0605965D0 (en) 2006-03-24 2006-05-03 Univ East Anglia Fluorescence based detection of substances
GB0618496D0 (en) * 2006-09-20 2006-11-01 Common Services Agency Blood typing
WO2010103405A2 (en) * 2009-03-11 2010-09-16 Jean-Pierre Robin Process for preparing cephalotaxine esters
JP5306901B2 (ja) 2009-05-25 2013-10-02 ベックマン コールター， インコーポレイテッド 血液型判定方法およびそのための赤血球固相化容器
FR2963108B1 (fr) * 2010-07-21 2017-06-23 Diagast Procede magnetique d'immunodiagnostic et kit pour la mise en evidence de complexe anticorps/antigene de groupe/phenotype sanguin
WO2012106442A1 (en) 2011-02-01 2012-08-09 Arryx, Inc. Centrifuge rotor for separation and processing of complex fluids

Also Published As

Publication number Publication date
JP2017508961A (ja) 2017-03-30
AU2015220566A1 (en) 2016-09-29
WO2015124947A1 (en) 2015-08-27
US20170059591A1 (en) 2017-03-02
AU2015220566B2 (en) 2020-10-15
CA2939789A1 (en) 2015-08-27
GB201403115D0 (en) 2014-04-09
CA2939789C (en) 2022-11-15
US10613102B2 (en) 2020-04-07
EP3108247A1 (en) 2016-12-28

Similar Documents

Publication Publication Date Title
JP5677835B2 (ja) 血液型抗体スクリーニング
JP6966197B2 (ja) 赤血球検出
RS61807B1 (sr) Antigenski čip
JP7425138B2 (ja) デジタルアッセイのために横からの照射を使用した光学イメージングシステム
JP5050058B2 (ja) 血液型の判定
US20180238876A1 (en) Method For Assessing Cell Surface Receptors of Blood Cells
JP2017508961A5 (https=)
JP4834075B2 (ja) 抗原検出
JP6708558B2 (ja) 血液サンプルの交差適合
JP6955261B2 (ja) マイクロアレイ、マイクロアレイの製造方法、検査方法、及び検査キット
CN119161464B (zh) 针对乙型肝炎病毒核心蛋白的单克隆抗体及其制备与应用
CN119161463A (zh) 一株乙型肝炎病毒核心蛋白的单克隆抗体cAbB4及其制备与应用

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20180220

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20180220

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20181206

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20181213

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20190313

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20190513

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20190926

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20191226

A524 Written submission of copy of amendment under article 19 pct

Free format text: JAPANESE INTERMEDIATE CODE: A524

Effective date: 20200226

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20200730

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20201030

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20210302

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20210701

C60 Trial request (containing other claim documents, opposition documents)

Free format text: JAPANESE INTERMEDIATE CODE: C60

Effective date: 20210701

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20210705

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20210819

C21 Notice of transfer of a case for reconsideration by examiners before appeal proceedings

Free format text: JAPANESE INTERMEDIATE CODE: C21

Effective date: 20210823

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20210921

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20211021

R150 Certificate of patent or registration of utility model

Ref document number: 6966197

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250